Dr. Shriver is a Clinical Professor of Ophthalmology and Visual Sciences and the Jim O’Brien Gross and Donnita Gross Chair of Ophthalmology at the University of Iowa in Iowa City.

1. Please share with us your background.

I grew up in Northern California, and I attended Pomona College and Stanford University School of Medicine. I then came to the University of Iowa for residency because of the family feel of the program, the focus on education, the relationship of the hospital within the greater university community, and the strong ophthalmic and oculoplastics traditions. I completed my American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) fellowship at Bascom Palmer Eye Institute and joined the faculty afterward, serving as the first full-time oculoplastics faculty member at the Palm Beach Gardens office. After nearly 5 years in practice, I returned to the University of Iowa for the opportunity to work closely with medical students, residents, and fellows and to collaborate with colleagues within ophthalmology and other fields.

Although I love clinical practice, I feel my life is enriched by my teaching, research, and advocacy efforts. I have been passionately involved in Women in Ophthalmology (WIO) for 10 years, having served as Chair of the Summer Symposium in 2013, on the Board of Directors since 2014, and President in 2021. I also have been active in the Iowa Academy of Ophthalmology and served as President of the society last year. It is an honor to represent my subspecialty society, ASOPRS, as Delegate to the American Medical Association, as well as Secretary of the ASOPRS Foundation, and Chair of the ASOPRS Thesis Committee.

When I am not working, I enjoy exercising and spending time with my husband and 12- and 9-year-old sons.

2. What is the focus of your recent research?

My research interests are all over the map. I have worked with medical students, residents, and fellows to investigate a range of topics, including novel surgical techniques in oculoplastics, analysis of current oculoplastic practices, objective metrics for eyelid position and aesthetics, thyroid eye disease treatments, patient-initiated sexual harassment of trainees, intimate partner violence in ophthalmic patients, the physics of eyelid malposition, and treatment of neuropathic orbital pain. I am driven to investigate problems that will improve patient care and the experience of my patients and fellow physicians.

I wasn’t naturally drawn to a career in research and did little research during my training. Several years into practice, however, I realized that I couldn’t take care of my patients as well as I wanted to because often there were no solid data to drive care management. My small field of oculofacial plastic and reconstructive surgery has so many unanswered questions that I came to realize I needed to start doing research in order to help each individual patient. I absolutely love having the opportunity to educate patients about the gaps in our knowledge of their condition and then later handing them a paper in which we tackled the question and found an answer to their problem.

3. What has your experience been collaborating with industry?

I had little interaction with industry during my training. In fact, there were many times when I felt as though relationships with industry were frowned upon. I credit Women in Ophthalmology for opening my eyes to the power of collaboration. Through my involvement with the organization, I met many bright and ethical women physicians who partnered with industry to a mutual benefit and, more importantly, to the benefit of their patients. I then had an opportunity to serve on an advisory board, and I loved it. I came away realizing that I have a lot to learn from leaders within industry, and I challenged myself to engage and collaborate with them when opportunities arise.

4. In your opinion, how is the role of women in ophthalmology evolving?

We are at an exciting time in the evolution of the role of women in our field. The situation has changed dramatically since I attended my first WIO meeting as a fellow in 2007. We still have a long way to go, but we are seeing an increasing number of women in leadership positions within organized and academic ophthalmology. Of the 44 past presidents of AAO, only five have been women. Three of those five women have served in the past 5 years, however. These women trailblazers are changing the discussion and leading the transformation.

We have also had exponential growth in the number of women ophthalmologists engaging in the discussion of equality, objectively discussing gender data, and training for leadership. It has been such a pleasure to serve on the WIO board for the past 8 years as the organization and our impact has grown nationally and internationally. More progress is still needed in the areas such as leadership, academics, income, subspecialization, harassment, career satisfaction, and gender roles at home, but we are heading in the right direction and the momentum is building.

5. What hurdles do you feel women in health care still face?

There are many areas where progress is still needed for women within health care, such as leadership opportunities, harassment, and the gender pay gap. Lack of flexibility in work hours and childcare resources compounded with the traditional gender roles within families and in society have also taken an increased toll on women. The COVID-19 pandemic has exacerbated this disparity, unfortunately. We need to change the discussion and expectations surrounding gender roles within families and in society in order to truly effect change; however, in the meantime, increased resources for caregivers and flexibility of work hours could have a significant beneficial impact on gender equality.

6. What advice can you offer to young female ophthalmologists who are still in training or just beginning their careers?

Be patient with yourself and understand that you can’t do everything at once. There may be times in your life when you choose to be less intense in your career to allow you to focus more on your family, health, or other pursuits, and that time won’t hold you back. Sure, you won’t be exactly where you would have been in your career if you hadn’t backed off a bit, but your life will be much richer for doing so.

I also think it is important to follow your passions. Your time is precious. Take a few moments to enjoy getting to know your patients on a personal level. Pick the advocacy, research, or community activities outside of clinical practice that you really care about. Get involved in your state society, subspecialty society, organized medicine, etc. These aspects of my career have been incredibly rewarding in terms of making connections, meeting wonderful people with similar passions, and advocating for my patients, field, and profession.

7. Can you propose a unique or creative idea that may help women in ophthalmic practices?

Amy Schefler, MD, taught me the concept of determining how much time you want for yourself or your family outside of work and scheduling it. Quantifying this time and setting a desired goal felt artificial at first, but it proved to be a useful tool. When my kids were younger, I set 6:00–8:30 pm as protected family time. If I didn’t have urgent patient care issues, those hours were off-limits. This helped me to work more productively before and after that protected window, and anything that came up had to be important enough to warrant breaking up the protected time (and justifying it to my family). During the protected time, I made every effort to focus on my family and put my phone and work issues aside. I also tried to talk about my “family time” with my colleagues and chair and, when declining conflicting invitations, to attempt to normalize it. As my kids have grown a little older, I haven’t adhered to formal protected time as much, but the concept served me well, and I was able to apply it to self-care as well.

PROFESSIONAL SOCIETY MEMBERSHIPS

• American Academy of Ophthalmology (AAO) | 2014–Present
• Practicing Ophthalmologists Curriculum, Oculoplastics/Orbit Panel 2015–2019
• Meeting Ambassador, Program Participant | 2019
• Leadership Development Program, Sponsored by WIO | 2017
• Annual Meeting Program Committee, Oculoplastics Reviewer | 2012–2016
• American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) | 2011–Present
• Strategic Exercise Advisory Committee | 2020–Present
• American Medical Association Delegate, Nonvoting Member of ASOPRS Executive Committee | 2019–Present
• ASOPRS Foundation Board, Secretary | 2018–Present
• ASOPRS ASOPRS Ad Hoc Global Opportunities Committee | 2018–Present
• ASOPRS Foundation Board | 2017–Present
• Associate Preceptor, Fellowship, University of Iowa | 2012–Present
• Educational Committee, Thesis Evaluation Subcommittee2017–2021
• Educational Committee, Fellowship Evaluation Subcommittee 2016–2021
• Educational Committee | 2014–2021
• American Medical Association Alternate Delegate, Nonvoting Member of ASOPRS Executive Committee | 2016–2019
• Oral Examiner | 2015, 2016, 2017
• Associate Preceptor, Fellowship, Bascom Palmer Eye Institute 2011–2012
• Women in Ophthalmology (WIO) | 2011–Present
• WIO Councilor, International Council of Ophthalmology2018–Present
• Board of Directors (Director) | February 2014–Present
• Cofounder of WIO, Iowa Chapter, SecretaryOctober 2013–Present
• Chair, WIO Nominating Committee | 2021
• Finance Committee Member | 2021
• Past President | 2021
• President | 2020
• Founder and Chair, Women Ophthalmologists of the World: A Global Vision for the Future | 2020
• President-Elect | 2019–2020
• Director of Mentorship Program | 2011
• American Medical Association | 2016–Present
• ASOPRS Delegate | 2020–Present
• ASOPRS Alternate Delegate | 2016–2019
• Selected for Reference Committee, AMA House of Delegates Interim Meeting | 2019
• Member, Surgical Caucus; Section Council of Plastic, Reconstructive & Maxillofacial Surgery; Federation of Specialty Plastic Surgery Societies; Ophthalmology Section Council; North Central Medical Conference; Women Physician Section Council
• Iowa Academy of Ophthalmology (IAO) | 2013–Present
• IAO Councilor to AAO | Accepted for 2022–2024
• Immediate Past President 2020 | 2020–Present
• Board of Directors | 2014–Present
• President | 2018–2020
• President-Elect | 2017–2018
• Vice President, Professional Education | 2014–2017
• Women Ophthalmologists Worldwide | 2020–Present
• Founding Member | 2020
• Regional Lead, North America | 2020–Present
• American College of Surgeons (ACS), Fellow | 2012–Present
• Member, ACS Intimate Partner Violence Task Force2019–Present
• North American Society of Academic Orbital Surgeons2017–Present
• Iowa Medical Society | 2013–Present
• Florida Medical Association | 2008–2012
• Florida Society of Ophthalmology | 2008–2012
• Palm Beach County Ophthalmology Society | 2008–2012

HONORS AND AWARDS

• The Power List 2021, The Ophthalmologist | 2021
• Inspiration Award, American Medical Association Women Physician Section | 2021
• Orkan G. Stasior Leadership Award, ASOPRS | 2020
• America’s Top Physicians | 2014–2020
• Summer Research Fellowship Outstanding Mentor in Clinical Research, University of Iowa Carver College of Medicine Medical Student Research Day | 2019
• Regional Top Doctor | 2019
• Best Doctors in America | 2011–2019
• Second Place Abstract, University of Iowa Hospitals and Clinics GME Symposium | 2018
• Resident Teaching Award, Department of Ophthalmology, University of Iowa | 2018
• Medical Student Teaching Award, Department of Ophthalmology, University of Iowa | 2017
• Secretariat Award, AAO | 2016
• Teaching Award, Department of Ophthalmology, University of Iowa | 2015
• Medical Student Teaching Award, Department of Ophthalmology, University of Iowa | 2015
• Achievement Award, AAO Board of Trustees | 2015
• Emerging Leader Award, WIO | 2015
• Best Poster, AAO Annual Meeting (Poster: P0465) | 2014
• Candidate, Marvin Quickert Thesis Award, ASOPRS Fall Scientific Symposium | 2011
• Cambridge Who’s Who Registry of Healthcare Professionals | 2011
• Transitional Intern of the Year, Santa Clara Valley Medical Center | 2003
• Associate Member Sigma Xi, Pomona College | 1997
• Cum Laude, Pomona College | 1997
• Pomona College Scholar, Pomona College | 1993–1997
• Arvid Pierre Zetterberg Award, Top Freshman Scholar-Athlete, Pomona College | 1994

PUBLISHED WORKS

• Hock LE, Barlow PB, Scruggs BA, et al. Tools for responding to patient-initiated verbal sexual harassment: a workshop for trainees and faculty. MedEdPortal. 2021;17:11096.
• Simmons BA, Clark TJE, Kuiper JJ, et al. Closure technique and antibiotics in frontalis sling infection and exposure. Ophthalmology. 2021;128(3):480-482.
• Yom KH, Shriver EM, Carter KD, et al. Reply re: The effect of photographic visual aids in preoperative patient counseling in oculoplastic surgery. Ophthalmic Plast Reconstr Surg. 2021;37(2);191.
• Ramirez DA, Dawoud SA, Simmons BA, Silverman WB, Shriver EM. Biliary obstruction-induced coagulopathy with subperiosteal orbital hemorrhage after endoscopic retrograde cholangiopancreatography. Can J Ophthalmol. 2021;S0008-4182(21)00122-8.
• Yom KH, Simmons BA, Hock LE, et al. A direct transcutaneous approach to infrorbital nerve biopsy. Orbit. 2021;6:1-8.
• Warren AK, Shriver EM. Medial canthal fistula in chronic canaliculitis. Ophthalmic Plast Reconstr Surg. 2021;37(3S):S169.
• Yom KH, Shriver EM, Carter KD, et al. The effect of photographic visual aids in preoperative patient counseling in oculoplastic surgery. Ophthalmic Plast Reconstr Surg. 2021;37(3S):S70-S75.
• Tran AQ, Zhang-Nunes SX, Cahill K, et al. Thyroid eye disease with choroidal folds. Orbit. 2021;40(3):206-214.
• Dawoud SA, Cohen AR, Renner LM, et al. Detection and referral of orbital and ocular injuries associated with intimate partner violence following an educational and screening initiative in an emergency department. JAMA Ophthalmol. 2021;139(7):785-789.
• Kupcha AC, Simmons BA, Law JJ, et al. Association of age-adjusted Charlson comorbidity index with orbital fungal disease outcomes [published online June 4, 2021]. Ophthalmic Plast Reconstr Surg. doi:10.1097/IOP.0000000000001987
• Sobel RK, Ford JR, Dong W, et al. Frequency and clinical course of residual orbital masses after treatment of orbital rhabdomyosarcoma. Am J Ophthalmol. 2021;S0002-9394(21)00365-2
• Tran C, Pham CM, Simmons BA, et al. Echographic assessment of extraocular muscle response to teprotumumab [published online ahead of print October 13, 2021]. Ophthalmic Plast Reconstr Surg. 2021. doi:10.1097/IOP.0000000000002072
• Yu CY, Correa T, Simmons BA, Hansen MR, Shriver EM. Audiology findings in patients with teprotumumab associated otologic symptoms. Am J Ophthalmol. 2021;24:101202.
• Aninye IO, Digre K, Hartnett ME, et al. The roles of sex and gender in women’s eye health disparities in the United States. Biol Sex Differ. 2021;12(1):57.
• Tran C, Choi D, Ko AC, Carter KD, Shriver EM. The effect of sleep position preference on eyelid and eyebrow symmetry [published online ahead of print October 13, 2021]. Ophthalmic Plast Reconstruct Surg. doi:10.1097/IOP.0000000000002066
• Mortensen ZQ, Simmons BA, Shriver EM, Carter KD, Downes SJ. Scleral contact lens as initial management in a neonate with a large congenital upper eyelid coloboma [published online ahead of print September 24, 2021]. Ophthalmic Plast Reconstr Surg. doi:10.1097/IOP.0000000000002057
• Evans JA, Shaheen MS, Clark TJE, Shriver EM. Aesthetic eyelid measurements of “beautiful people”: gender differences and application for thyroid eye disease patients. Plast Reconstr Surg Glob Open. 2021;9(7):e3666.
• Gill H, Niederer RL, Shriver E, et al. An eye on gender equality: a review of the evolving role and representation of women in ophthalmology. Am J Ophthalmol. 2021;S0002-9394(21)00372-X.
• Radmall BR, Idowu OO, Vagefi MR, Carter KD, Shriver EM. Challenging the current treatment of residual postoperative ptosis: safety and efficacy of repeat Müller’s muscle conjunctival resection. Can J Ophthlamol. 2021;S0008-4182(21)00165-4.
• Cohen AR, Shriver EM. Intimate partner violence. Women’s Eye Health. April 2021.
• Shriver EM, Pine K, Bohman E. Maintenance of the anophthalmic socket. In: Johnson TJ, ed. Anophthalmia: The Expert’s Guide to Medical and Surgical Management. 1st ed. New York, NY: Springer Publishing; 2020.
• Scruggs BA, Hock LE, Cabrera MT, et al. A U.S. survey of sexual harassment in ophthalmology training using a novel standardized scale. J Acad Ophthalmol. 2020;12:e27-e35.
• Lin AC, Shriver EM. The role of pembrolizumab in the treatment of sebaceous carcinoma. Int Ophthalmol Clin. 2020;60(2):39-46.
• Fox A, Janson B, Stiff H et al. A multidisciplinary educational curriculum for the management of orbital compartment syndrome. Am J Emerg Med. 2020;38(6):1278-1280.
• Mai AP, Fortenbach CR, Wibbenmeyer LA, Wang K, Shriver EM. Preserving vision: rethinking burn patient monitoring to prevent orbital compartment syndrome. J Burn Care Res. 2020;41(5):1104-1110.
• Hock LE, Scruggs BA, Barlow PB, et al. Responding to patient-initiated verbal sexual harassment: outcomes of a pilot training for ophthalmologists. J Acad Ophthalmol. 2020(2):e175-e180.
• Yu CY, Simmons BA, Greenlee JD, et al. Orbital actinomyces masquerading as meningioma. Ophthalmic Plast Reconstr Surg. 2020;36(5):e124-e126.
• Cohen AR, Renner LM, Clark TJ, Shriver EM. Surgeons’ guide to intimate partner violence in the era of COVID-19. Bulletin of the American College of Surgeons. October 2020.
• Yom KH, Mai AP, Fortenbach CR, et al. Orbital compartment syndrome in a burn patient. EyeRounds. May 2020.
• Zhang H, Hock LE, Robinson R, et al. Maxillary sinus mucocele. EyeRounds. April 2020.
• Liaboe CA, Simmons BA, Clark TJ, Shriver EM. Thyroid eye disease: a summary of information for patients. EyeRounds. March 2020.
• Liaboe CA, Clark TJ, Simmons BA, Carter KD, Shriver EM. Thyroid eye disease: an introductory tutorial and overview of disease. EyeRounds. April 2020.
• Choi D, Benage M, Radmall BR, Ko AC, Shriver EM. Acute post-traumatic direct carotid cavernous fistula. EyeRounds. December 2019.
• Hock LE, Scruggs BA, Oetting TA, Abramoff MD, Shriver EM. Tools for responding to patient-initiated verbal sexual harassment. EyeRounds. August 2019.
• Epitropoulos AT, Shriver EM. Don’t let DED mar a perfect eye lift. Ophthalmology Management. April 2019.
• Kirkpatrick CA, Shriver EM, Clark TJ, Kardon RH. Upper eyelid response to topical 0.5% apraclonidine. Ophthalmic Plast Reconstr Surg. 2018;34(1):13-19.
• Evans JA, Clark TJE, Zimmerman MB, et al. Rethinking our definition of postoperative success: a comparative analysis of three upper eyelid retraction repair techniques using novel metrics to capture functional and aesthetics outcomes. Ophthalmic Plast Reconstr Surg. 2018;34(1):55-63.
• Chahal HS, Estrada M, Sindt CW, et al. Scleral contact lenses in an academic oculoplastics clinic: epidemiology and emerging considerations. Ophthalmic Plast Reconstr Surg. 2018;34 (3):231-236.
• Clark TJE, Klejch WJ, Wang K, et al. Hering’s law in congenital ptosis: evaluation of the contralateral response to unilateral congenital ptosis repair. Ophthalmic Plast Reconstr Surg. 2018;34(3):284-290.
• Shriver EM, Bartley GB. Vision loss in orbital surgery: a call to action for orbital surgeons. Ophthalmology. 2018;125(7):1109.
• Evans JA, Clark TJE, Wang K, Shriver EM. Effect of iris show on perceived upper eyelid height. Can J Ophthalmol. 2018;53(5):462-465.
• Canady FJ, Ricca AM, Stiff HA, Shriver EM, Ko AC. Self-resolving ischemic third nerve palsy. EyeRounds. October 2018.
• Stiff HA, Chung AT, Benage M, et al. Orbital compartment syndrome curriculum. EyeRounds. September 2018.
• Yom KH, Ricca AM, Shriver EM, Ko AC. Enucleation and evisceration: what to expect. EyeRounds. September 2018.
• Shriver EM. Minor modification, major impact. The Ophthalmologist. September 2018.
• Shriver EM. A global call to action. The Ophthalmologist. September 2018.
• Kennedy S, Scruggs BA, Fox AR, Larson SA, Shriver EM. Localized orbital amyloidosis presenting as new-onset diplopia. EyeRounds. August 2018.
• Sampson A, Fox AR, Howard MA, Shriver EM. Cholesterol granuloma. EyeRounds. January 2018.
• Ricca AM, Kim AK, Chahal HS, Shriver EM. Nasolacrimal stents: an introductory guide. EyeRounds. January 2018.
• McConnell LK, Syed NA, Zimmerman MB, et al. An analysis of conjunctival map biopsies in sebaceous carcinoma. Ophthalmic Plast Reconstr Surg. 2017;33(1):17-21.
• Baker MS, Yin VT, Ivan D, et al. Epidemiology and prognosis of primary periocular sweat gland carcinomas. Ophthalmic Plast Reconstr Surg. 2017;33(2):101-105.
• Lenci LT, Shams P, Shriver EM, Allen RC. Dermoid cysts: clinical predictors of complex lesions and surgical complications. J AAPOS. 2017;21(1):44-47.
• Smith TJ, Kahaly GJ, Ezra DG, et al. Teprotumumab for thyroid-associated ophthalmology. N Engl J Med. 2017;376(18):1748-1761.
• Chung AT, Lenci LT, Wang K, et al. Effect of fine-motor-skill activities on surgical simulator performance. J Cataract Refract Surg. 2017;43(7):915-922.
• Provencher LM, Shriver EM, Alward WLM. Ptosis masquerading as progression of severe glaucoma. JAMA Ophthalmology. 2017;135(9):e172788.
• Cohen AR, Renner LM, Shriver EM. Intimate partner violence in ophthalmology: a global call to action. Curr Opin Ophthalmol. 2017; 28(5):534-538.
• Smith CA, De Andrade LM, Carter KD, Shriver EM. Fibrous dysplasia. EyeRounds. October 2017.
• Andreasen NS, Clark TJ, Sun D, Hansen M, Shriver EM. Bell’s palsy treated with facial nerve decompression. EyeRounds. August 2017.
• Lenci LT, Kirkpatrick CA, Clark TJ, et al. Benign lesions of the external periocular tissues: a tutorial. EyeRounds. June 2017.
• Lenci LT, Sciegienka SJ, Kirkpatrick CA, et al. Malignant lesions of the external periocular tissues: a tutorial. EyeRounds. June 2017.
• Stump M, McConnell LK, Chahal, HS, Shriver EM. Oculoplastic basic instrument tray. EyeRounds. March 2017.
• Liaboe CA, Clark TJ, Shriver EM. Thyroid eye disease, a summary of information for patients. EyeRounds. January 2017.
• Clark TJ, Rao K, Quinn CD, Batlle JF, et al. A vector force model of upper eyelid position in the setting of a trabeculectomy bleb. Ophthalmic Plast Reconstr Surg. 2016;32(2):127-132.
• Shriver EM, Erickson BP, Kossler AL, Tse DT. Lateral canthal tendon disinsertion: clinical characteristics and anatomical correlates. Ophthalmic Plast Reconstr Surg. 2016;32(5):378-385.
• Kossler AL, Erickson BP, Shriver EM, Tse DT. The locking Y lateral canthopexy with osseous integration: clinical experience and surgical technique. Ophthalmic Plast Reconstr Surg. 2016;32(5):386-392.
• Shams PN, Policeni B, Carter KD, Shriver E, Thurtell MJ. Bilateral septic cavernous sinus thrombosis, congestive orbitopathy, and ischemic optic neuropathy. Can J Ophthalmol. 2016;51(2):e7.
• Baker MS, McConnell LK, Kleinber TT, et al. Orbital sarcomas in retinoblastoma patients: recommendations for screening and treatment guideline. Curr Opin Ophthalmol. 2016;27(5):443-448.
• Kuiper JJ, Zimmerman MB, Pagedar NA, et al. Perception of patient appearance following various methods of reconstruction after orbital exenteration. Orbit. 2016;35(4):187-192.
• McConnell LK, Duffel PG, Lee WW, Black DW, Shriver EM. Reply re: Beauty is in the eye of the beholder: body dysmorphic disorder in ophthalmic plastic reconstructive surgery. Ophthalmic Plast Reconstr Surg. 2016;32(5):403.
• Tenzel PA, Patel K, Erickson BP, et al. Split face evaluation of long-pulsed non-ablative 1,064 nm Nd:Yag laser for treatment of direct browplasty scars. Lasers Surg Med. 2016;48(8):742-747.
• Liaboe CA, Clark TJ, Carter KD, Shriver EM. Thyroid eye disease: an introductory tutorial and overview of disease. EyeRounds. November 2016.
• Greenwald MF, Meirick BS, McConnell LK, Shriver EM. Conjunctival lymphoma. EyeRounds. September 2016.
• Myers LA, Vogelgesang SA, Kardon RH, Gordon LK, Shriver EM. Idiopathic orbital myositis: a treatment algorithm. EyeRounds. May 2016.
• McConnell LK, Lee WW, Black DW, Tse DT, Shriver EM. Beauty is in the eye of the beholder: body dysmorphic disorder in ophthalmic plastic and reconstructive surgery. Ophthalmic Plast Reconstr Surg. 2015;31(1):e3-e6.
• Estrada MM, Baker MS, Sobel RK, Shriver EM, Allen RC. Re: localization and retrieval of an eyelid metallic foreign body with an oscillating magnet and high-resolution ultrasonography. Ophthalmic Plast Reconstr Surg. 2015;31(2):159-160.
• Savage MW, Sobel RK, Hoffman HT, et al. Salivary gland dysfunction and nasolacrimal obstruction: stenotic changes following I-131 therapy. Ophthalmic Plast Reconstr Surg. 2015;31(3):e50-e52.
• Clark TJE, Shriver EM. Emergent evaluation of eyelid lacerations: a guide for ophthalmology residents. EyeRounds. December 2015.
• Scott J, Beebe JM, Shriver EM. Nasolacrimal duct obstruction secondary to sarcoidosis. EyeRounds. October 2015.
• Clark TJE, Lenci LT, Allen, RC, Shriver, EM. Involutional entropion: options for surgical management of entropion. EyeRounds. September 2015.
• Clark TJ, Shriver EM. Intimate partner violence (IPV) awareness: ASK, ASSESS, REFER. EyeRounds. April 2015.
• Shriver EM. “What can I do about … ?” A primer to manage your patients’ eye-related skincare questions. ASCRS Ophthalmology Business Magazine. March 2015.
• Jivraj I, Baker M, Mallery R, Shriver EM. "I can't read": a review of the ophthalmological features of Parkinson's disease. EyeRounds. February 2015.
• Jivraj I, Baker M, Shriver EM. "I can't open my eyes": a case of blepharospasm and apraxia of eyelid opening. EyeRounds. February 2015.
• Perry CB, Lenci L, Shriver EM. Orbital lymphatic malformation (lymphangioma). EyeRounds. January 2015.
• Niles PI, Cohen A, Sacher B, et al. Firework-related ocular injuries. EyeRounds. January 2015.
• Shriver EM. Role of ophthalmologists in helping victims of violence. EyeWorld. October 2014.
• Weed M, Shriver EM, Longmuir R. Dramatic visual recovery in untreated indirect traumatic optic neuropathy. EyeRounds. February 2014.
• Shriver EM. Giving patients a boost. EyeWorld. December 2014.
• Mears KA, Sobel RK, Shriver EM, Sohn EH. Endophthalmitis secondary to globe penetration from hydrogel scleral buckle. Int J Ophthalmol. 2014;7(3):585-6.
• Clark TJ, Dubovy SR, Shriver EM. Case of the weeping formation of a lacrimal pseudocyst following lateral canthal surgery. Ophthalmic Plast Reconstr Surg. 2014;30(5):e128-e31.
• Alabiad CR, Weed DT, Walker TJ, et al. En bloc resection of lacrimal sac tumors and simultaneous orbital reconstruction—surgical and functional outcomes. Ophthalmic Plast Reconstr Surg. 2014;30(6):459-467.
• Clark TJ, Renner LM, Sobel RK, et al. Intimate partner violence (IPV): an under recognized and underappreciated etiology of orbital floor fractures. Ophthalmic Plast Reconstr Surg. 2014;30(6):508-511.
• Shriver EM, Ragheb J, Tse DT. A combined transcranial-orbital approach for resection of optic nerve gliomas: a clinical and anatomical study. Ophthalmic Plast Reconstr Surg. 2012;28(3):184-191.
• Tse BC, Shriver EM, Tse DT. Tarsoconjunctival crypts: an unrecognized source of chronic mucopurulent conjunctivitis. Am J Ophthalmol. 2012;154(3):527-533.
• Shriver EM. Post-surgical ptosis: causes and treatments. EyeWorld. November 2012.
• Johnson TJ, Hui JI, Shriver EM, Alabiad C. Management of orbital cellulitis. In: Yen MT, ed. Surgery of the Eyelids, Lacrimal System and Orbit. 2nd ed. New York, NY: Oxford University Press; 2012: 289-302.
• Tse DT, Shriver EM. Lateral canthopexy. In: Tse DT, ed. Color Atlas of Oculoplastic Surgery. 2nd ed. Philadelphia, PA: Wolters Kluwer, Lippincott Williams & Wilkins; 2011: 76-81.
• Hui JI, Shriver EM, Tse DT. Intubation of the ostium and nasolacrimal duct with a single self-linking silicone stent in external dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg. 2011;27(2):87-89.
• Shriver EM, McKeown C, Johnson TE. Trochlear calcification mimicking an orbital foreign body. Ophthalmic Plast Reconstr Surg. 2011;27(6):e143-144.
• Tse DT, Shriver EM, Krantz KB, et al. The use of titanium T-plate as platform for globe alignment in severe paralytic strabismus. Am J Ophthalmol. 2010;150(3):404-411.
• Shriver EM. Droopy eyelids, bags and crow’s feet. Palm Beach Post. August 2009.
• Robinson C, Tantri A, Shriver E, Oetting T. Temporary eyelid closure appliqué. Arch Ophthalmol. 2006;124(4):546-549.
• Shriver EM. Cavernous hemangioma: 31-year-old Caucasian female with a painless, dark spot in her left visual field. EyeRounds. February 2005.
• De Kaspar HM, Chang RT, Shriver EM, et al. Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery: a prospective randomized study. Ophthalmology. 2004;111(7):1352-1355.
• Ta CN, Chang RT, Singh K, et al. Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology. 2003;110(10):1946-1951.
• Mino de Kaspar H, Shriver EM, Nguyen EV, et al. Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefes Arch Clin Exp Ophthalmol. 2003;241(9):730-733.
• Ta CN, Egbert PR, Singh K, et al. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology. 2002;109(11):2036-2040.
• Moore Shriver E. The athletic advantage, how I transformed my student years by competing in sports. Imagine, The Johns Hopkins University Press. March/April 1997.